🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. Kanglaite Injection+Chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC

    approved small molecule active

    1 trial

  2. Kesimpta 20 mg solution for injection in pre-filled syringe

    Novartis Pharmaceuticals

    Relapsing forms of Multiple Sclerosis (RMS)

    approved small molecule active

    1 trial

  3. Ketorolac Injection

    United Therapeutics Europe Ltd

    Orthopaedic Trauma

    approved small molecule active

    1 trial

  4. Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel

    Almirall, S.A.

    Actinic Keratosis

    approved small molecule active

    1 trial

  5. LABA/LAMA or Placebo inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis Adult

    approved small molecule active

    1 trial

  6. LACTOSE MONOHYDRATE, Clopidogrel Viatris 75 mg film coated tablets, Acetylsalicylzuur Aurobindo cardio 80 mg, tabletten., Clopidogrel Zentiva 75 mg film-coated tablets

    Disc Medicine

    (Chronic) Peripheral (occlusive) arterial disease (PAD)

    approved small molecule active

    1 trial

  7. LIVTENCITY 200 mg film-coated tablets.

    The George Institute

    Transplant patients with high recurrent Epstein-Barr infection

    approved small molecule active

    1 trial

  8. LORLATINIB

    Pfizer Australia Pty Ltd

    Lung cancer

    approved small molecule active

    1 trial

  9. LV dp/dt pressure measurement

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  10. LacTEST 0,45 g polvo para solución oral.

    Lacuna Pharma Pty Ltd

    Lactose intolerance

    approved small molecule active

    1 trial

  11. Lanreotide Autogel 120 mg

    Ipsen

    Acromegaly

    approved small molecule completed

    1 trial

  12. Lansoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    1 trial

  13. Lansoprazole

    Takeda

    Functional Dyspepsia

    approved small molecule terminated

    1 trial

  14. Lansoprazole (Prevacid)

    Takeda

    Zollinger-Ellison Syndrome

    approved small molecule completed

    1 trial

  15. Lanthanum carbonate

    Takeda

    Kidney Diseases

    approved small molecule terminated

    2 trials

  16. Lanthanum carbonate

    Takeda

    Kidney Failure, Chronic

    approved small molecule completed

    6 trials

  17. Lantus 100 units/ml solution for injection in a cartridge, Lantus 100 units/ml solution for injection in a vial, Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Awiqli 700 units/mL solution for injection in pre-filled pen, Levemir FlexPen 100 units/ml solution for injection in pre-filled pen., Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Tresiba 200 units/mL FlexTouch solution for injection in pre-filled pen, Tresiba 100 units/mL FlexTouch solution

    NovoThirteen

    Type 2 diabetes

    approved small molecule active

    1 trial

  18. Ledipasvir 90mg/Sofosbuvir 400 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  19. Leucovorin calcium

    Ultragenyx UK Limited

    Toxoplasmosis

    approved small molecule active

    1 trial

  20. Levobupivacaine

    United Therapeutics Europe Ltd

    Arthroplasty, Replacement, Knee

    approved small molecule active

    1 trial

  21. Levosimendan Kalceks 2,5 mg/ml concentraat voor oplossing voor infusie, Soluvit N poeder voor oplossing voor intraveneuze infusie

    Disc Medicine

    Failure to wean from invasive ventilation.

    approved small molecule active

    1 trial

  22. Liposomal Bupivacaine

    Pacira Ireland Limited

    Male Infertility

    approved small molecule completed

    1 trial

  23. Liposomal Bupivacaine Infiltration

    Pacira Ireland Limited

    Postoperative Pain

    approved small molecule terminated

    1 trial

  24. Liposomal bupivacaine

    Blackmores Limited

    Liposomal Bupivacaine

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources